SCHEMBL18318971

SCHEMBL18318971

CN(C)c1nccc2cc(-c3ccc(OC4CCNCC4)cc3)ccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 6/20 0.56
KHK P50053 1/20 0.45
IKBKB O14920 1/20 0.44
ROCK2 O75116 2/20 0.43
PRKACA P17612 1/20 0.43
PRKCD Q05655 1/20 0.43
PRKG1 Q13976 1/20 0.43
PKN1 Q16512 1/20 0.43
PKN2 Q16513 1/20 0.43
AAK1 Q2M2I8 1/20 0.43
CDC42BPA Q5VT25 1/20 0.43
Q6ZSR9 Q6ZSR9 1/20 0.43
BMP2K Q9NSY1 1/20 0.43
CDC42BPB Q9Y5S2 1/20 0.43
KCNH2 Q12809 2/20 0.42
PRKCZ Q05513 2/20 0.41
HRH3 Q9Y5N1 1/20 0.41
TLR9 Q9NR96 1/20 0.40
TLR8 Q9NR97 1/20 0.40
TLR7 Q9NYK1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12192951 0.91 ROCK1 (0.67) ROCK1KHKIKBKBROCK2PRKACA
SCHEMBL18318673 0.85 ROCK1 (0.59) ROCK1KHKIKBKBROCK2PRKACA
SCHEMBL18318377 0.83 ROCK1 (0.57) ROCK1KHKIKBKBROCK2PRKACA
SCHEMBL18322857 0.82 ROCK1 (0.81) ROCK1KHKIKBKBROCK2PRKACA
SCHEMBL18318650 0.82 ROCK1 (0.59) ROCK1KHKIKBKBROCK2PRKACA
SCHEMBL18319500 0.82 ROCK1 (0.56) ROCK1KHKIKBKBROCK2PRKACA
SCHEMBL18318699 0.82 KHK (0.57) ROCK1KHKIKBKBROCK2PRKACA
SCHEMBL18318948 0.81 ROCK1 (0.58) ROCK1KHKIKBKBROCK2PRKACA
SCHEMBL18318498 0.77 ACACB (0.35) ROCK1ROCK2KCNH2HRH3
SCHEMBL18318332 0.77 CHEK2 (0.50) HRH3CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257035-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2025-08-14 US disclosed
US-12098130-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2024-09-24 US disclosed
US-20230391723-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2023-12-07 US disclosed
US-11702388-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2023-07-18 US disclosed
US-20210230116-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2021-07-29 US disclosed
CN-107847765-B 1, 4-substituted piperidine derivatives 89生物有限公司 2021-05-04 CN disclosed
US-10851057-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2020-12-01 US disclosed
EP-3310441-B1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES 89BIO LTD (IL) 2020-07-29 EP disclosed
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2019-05-23 US disclosed
US-10221135-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2019-03-05 US disclosed
US-20180179159-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2018-06-28 US disclosed
EP-3310441-A1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES Cephalon, Inc. (US) 2018-04-25 EP disclosed
US-9902696-B2 1,4-substituted piperidine derivatives CEPHALON, INC. (US) 2018-02-27 US disclosed
WO-2016205633-A1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON, INC. (US) 2016-12-22 WO disclosed
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257035-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A ROCK1 2370/4885KHK 962/4885IKBKB 1701/4885
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A ROCK1 2370/4885KHK 962/4885IKBKB 1701/4885
US-20230391723-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A ROCK1 2370/4885KHK 962/4885IKBKB 1701/4885
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A ROCK1 2370/4885KHK 962/4885IKBKB 1701/4885
US-20210230116-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A ROCK1 2370/4885KHK 962/4885IKBKB 1701/4885
US-10221135-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A ROCK1 2370/4885KHK 962/4885IKBKB 1701/4885
US-11702388-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A ROCK1 2370/4885KHK 962/4885IKBKB 1701/4885
US-12098130-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A ROCK1 2370/4885KHK 962/4885IKBKB 1701/4885
US-10851057-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A ROCK1 2370/4885KHK 962/4885IKBKB 1701/4885
US-20180179159-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A ROCK1 2507/4885KHK 924/4885IKBKB 1545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.